High margin Medacta leads the way in pre-Easter IPO reopening

Medacta, the Swiss maker of artificial human joints, has begun a process to list on the SIX Swiss Exchange before Easter. If it succeeds, it would be the first major company to complete an IPO in Europe this year.

  • By Sam Kerr
  • 11 Mar 2019

Credit Suisse and Morgan Stanley are global coordinators, JP Morgan and UBS bookrunners.

The IPO consists of an all-secondary share sale by the family of Alberto Siccardi, who founded the company in 1999 and remains its chairman. Francesco Siccardi is the CEO.

Medacta’s main offerings are ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

All International Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 19 Sep 2019
1 JPMorgan 299,908.40 1348 8.58%
2 Citi 269,633.69 1139 7.71%
3 Bank of America Merrill Lynch 233,702.48 955 6.69%
4 Barclays 215,977.22 873 6.18%
5 Goldman Sachs 171,316.37 716 4.90%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 BNP Paribas 33,565.22 148 7.28%
2 Credit Agricole CIB 33,319.19 143 7.22%
3 JPMorgan 25,404.62 68 5.51%
4 Bank of America Merrill Lynch 23,368.44 65 5.07%
5 SG Corporate & Investment Banking 22,565.04 105 4.89%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 9,273.57 56 10.29%
2 Morgan Stanley 8,122.33 40 9.01%
3 Goldman Sachs 7,738.32 41 8.59%
4 Citi 6,426.54 47 7.13%
5 UBS 4,913.18 26 5.45%